Is MRSH a good stock to buy? We came across a bullish thesis on Marsh & McLennan Companies, Inc. on Ocular Capital’s Substack. In this article, we will summarize the bulls’ thesis on MRSH. Marsh & McLennan Companies, Inc.'s share was trading at $173.97 as of March 11th. MRSH’s trailing and forward P/E were 20.64 and 16.75 respectively according to Yahoo Finance.

everything possible/Shutterstock.com

Marsh & McLennan Companies, Inc. (MMC) operates as one of the world’s leading professional services firms focused on risk, strategy, and human capital, benefiting from a structural rise in global risk complexity. As corporations face increasing exposure to cyber threats, climate-related disruptions, and geopolitical uncertainty, the demand for sophisticated risk advisory and insurance brokerage services continues to expand.

Marsh & McLennan Companies, Inc. (MMC), alongside major industry peers such as Aon plc, functions within a highly concentrated brokerage and consulting market that resembles an oligopoly, where scale, expertise, and long-standing client relationships create formidable competitive advantages. The company’s business model is not capital intensive, relying instead on intellectual capital, advisory expertise, and deep institutional relationships with corporate clients, which together create high switching costs and recurring revenue streams.

As organizations become more complex and regulatory environments evolve, clients increasingly rely on Marsh & McLennan Companies, Inc. (MMC) to manage risk, optimize insurance coverage, and improve operational resilience. This dynamic enables the firm to steadily increase advisory fees while benefiting from operating leverage and margin expansion over time.

The combination of durable demand, recurring client engagement, and a strong competitive position within a consolidated industry supports consistent revenue growth and strong cash generation. As a result, Marsh & McLennan Companies, Inc. (MMC) is often viewed as a long-term compounder, positioned to benefit from the persistent need for professional risk advisory and brokerage services in an increasingly uncertain global environment.

Previously, we covered a bullish thesis on Brown & Brown, Inc. (BRO) by Bulls On Parade in April 2025, which highlighted the company’s decentralized brokerage model, acquisition-led growth strategy, and consistent organic revenue expansion supporting long-term compounding. BRO’s stock price has depreciated by approximately 42.47% since our coverage due to multiple compressions and sector rotation, not a collapse in fundamentals. Ocular Capital shares a similar view but emphasizes Marsh & McLennan Companies, Inc. (MRSH)’s oligopolistic brokerage position and rising global risk complexity.

Marsh & McLennan Companies, Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 69 hedge fund portfolios held MRSH at the end of the fourth quarter which was 66 in the previous quarter. While we acknowledge the risk and potential of MRSH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MRSH and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW

Disclosure: None.